Free Trial

Nutex Health (NASDAQ:NUTX) Reaches New 12-Month High - What's Next?

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $152.51 and last traded at $146.65, with a volume of 33020 shares. The stock had previously closed at $145.27.

Analyst Ratings Changes

Separately, Maxim Group raised their target price on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th.

Read Our Latest Stock Analysis on Nutex Health

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The company has a market cap of $745.59 million, a PE ratio of -14.51 and a beta of 0.27. The business has a fifty day simple moving average of $77.42 and a two-hundred day simple moving average of $49.32.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to analysts' expectations of $81.13 million.

Insider Transactions at Nutex Health

In other news, CFO Jon Christian Bates bought 1,000 shares of the stock in a transaction on Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 38.52% of the company's stock.

Institutional Trading of Nutex Health

Institutional investors have recently made changes to their positions in the business. Topline Capital Management LLC purchased a new stake in Nutex Health in the fourth quarter valued at about $5,690,000. American Century Companies Inc. acquired a new stake in Nutex Health in the 4th quarter worth approximately $1,362,000. Ancora Advisors LLC purchased a new stake in Nutex Health during the 4th quarter worth approximately $1,334,000. Drive Wealth Management LLC purchased a new stake in Nutex Health during the 4th quarter worth approximately $1,122,000. Finally, Essex Investment Management Co. LLC raised its holdings in shares of Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Stories

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines